本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Neurosense Therapeutics Ltd

1.22
-0.0421-3.34%
盘后1.220.00000.00%17:38 EDT
成交量:24.58万
成交额:30.43万
市值:2,921.58万
市盈率:-2.22
高:1.36
开:1.34
低:1.18
收:1.26
数据加载中...
2023/03/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/26

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/06

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/12/06

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/19

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/19

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/11/10

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/11/10

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/01

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers